Medications
Zurampic approved for gout
(HealthDay)—Zurampic (lesinurad) has been approved by the U.S. Food and Drug Administration to control blood levels of uric acid associated with gout.
Dec 23, 2015
0
1
Page 17 - News tagged with drug combinations
HIV & AIDS
Drug firm announces advance in quest for HIV cure
A Norwegian drug firm on Tuesday announced an advance in its quest for an HIV cure with a drug combination which seeks to force the virus out of its hiding place and kill it.
Dec 22, 2015
0
76
Medications
Netupitant/palonosetron for prevention of nausea and vomiting: Added benefit not proven
The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether the drug combination netupitant/palonosetron (trade name: Akynzeo) offers an added benefit over the appropriate ...
Nov 23, 2015
0
0
Oncology & Cancer
Cotellic approved for advanced melanoma
(HealthDay)—Cotellic (cobimetinib) in combination with another chemotherapy, vemurafenib (Zelboraf) has been approved by the U.S. Food and Drug Administration to treat melanoma skin cancer that has spread or cannot be surgically ...
Nov 10, 2015
0
4
Oncology & Cancer
Massive screen of drug combinations may find treatment for resistant, BRAF-mutant melanoma
A team of Massachusetts General Hospital (MGH) investigators has discovered a new combination of drugs that may be effective against one of the deadliest cancers, malignant melanoma. The combination - pairing a drug targeted ...
Oct 26, 2015
0
16
Oncology & Cancer
Cancer-driving signals cause high-risk neuroblastoma
Researchers have discovered details of the abnormal molecular signals and biological events that drive a high-risk form of the childhood cancer neuroblastoma. They aim to use these findings to develop more effective targeted ...
Oct 15, 2015
0
55
Oncology & Cancer
Antidepressants plus blood thinners cause brain cancer cells to eat themselves in mice
Scientists have been exploring the connection between tricyclic antidepressants and brain cancer since the early 2000s. There's some evidence that the drugs can lower one's risk for developing aggressive glioblastomas, but ...
Sep 24, 2015
0
9122
Cardiology
FDA approves new heart failure pill from Novartis
Government regulators have approved a new pill from Novartis to treat heart failure, a deadly chronic disease that affects millions of U.S. patients.
Jul 7, 2015
0
6
Psychology & Psychiatry
Drug combination highlights potential new depression treatment
Scientists at our University have identified that a combination of two existing licensed drugs could be used as a potential new treatment for depression.
Jun 15, 2015
0
114
Medications
Many fixed-dose drug combinations in India lack central regulatory approval
Fixed-dose drug combinations (FDCs) which have not received central regulatory approval are sold in substantial numbers in India—despite concerns over the safety and efficacy of these combinations—according to new research ...
May 12, 2015
0
6
